BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Sch23390

a selective D1-receptor antagonist Heading Mapped to: Benzazepines

126+ PubMed studies analyzed · Evidence Score: 41

Research Domains

Sch23390 has been studied across 13 research domains including 🌤️ Mood & Depression, 🧠 Focus & Attention, 🧠 Memory, 🧠 Learning, 🧘 Stress & Anxiety. The primary research focus is 🌤️ Mood & Depression with 94% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Sch23390, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

skf
2 shared targets
ecopipam
2 shared targets
sch
2 shared targets
r
2 shared targets
canadine
2 shared targets
tetrahydropalmatine
2 shared targets
bdb
2 shared targets
stepholidine
2 shared targets
ropinirole
2 shared targets
Tetrahydropapaveroline
2 shared targets
Loading evidence profile...

This evidence profile for Sch23390 is generated deterministically from 126 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.